SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion)
NCT: NCT07712666 · NOT_YET_RECRUITING
Brief Summary
The investigator hypothesizes intraoperative salvaged red blood cells are a poor substitute for allogenic packed red blood cell transfusions. In addition to providing inadequate resuscitation, salvaged red blood cells can increase the rate of complications, including postoperative electrolyte abnormalities, thrombocytopenia, anemia, and coagulopathy.
Frequently Asked Questions
What is SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion)?
SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion) is a clinical trial registered under NCT07712666. Current status: NOT_YET_RECRUITING.
What is the status of NCT07712666?
The current status of NCT07712666 (SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion)) is: NOT_YET_RECRUITING.
When did SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion) start?
SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion) started on 2026-08-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.